<DOC>
	<DOCNO>NCT00882323</DOCNO>
	<brief_summary>Anti-thymocyte globulin ( ATG ) use severe aplastic anemia part condition regimen . Among many kind ATG preparation , thymoglobulin find effective preventing graft versus host disease ( GVHD ) rejection organ transplant . As fludarabine base conditioning regimen without total body irradiation report promising transplantation alternative donor SAA , thymoglobulin add fludarabine cyclophosphamide conditioning reduce GVHD allow good engraftment unrelated donor transplantation . Our previous phase II study fludarabine , cyclophosphamide plus thymoglobulin conditioning result good engraftment ( 100 % ) survival rate ( 74 % ) . But grade III/IV toxicity occur 25 % patient event treatment related mortality . As cyclophosphamide toxic agent fludarabine , plan new phase II study ; 'reduced toxicity fludarabine , cyclophosphamide plus thymoglobulin conditioning regimen unrelated donor transplantation severe aplastic anemia ' reduce dosage cyclophosphamide increase dosage fludarabine .</brief_summary>
	<brief_title>Reduced Toxicity Fludarabine ( Flu ) + Cyclophosphamide ( CPM ) + Rabbit Antithymocyte Globulin ( rATG ) Conditioning Regimen Unrelated Donor Transplantation Severe Aplastic Anemia ( SAA )</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>1 . Diagnosis severe aplastic anemia define two three peripheral blood criterion either marrow criterion . Peripheral blood 1 . Neutrophils &lt; 0.5 x 109/l 2 . Platelets &lt; 20 x 109/l 3 . Corrected reticulocytes &lt; 1 % Bone marrow 1 . Severe hypocellularity ( &lt; 25 % ) 2 . Moderate hypocellularity ( 2530 % ) hematopoietic cell represent &lt; 30 % residual cell 2 . No prior hematopoietic stem cell transplantation . 3 . Age : limit . 4 . Performance status : ECOG 02 . 5 . Patients must free significant functional deficit major organ , follow eligibility criterion may modify individual case : Heart : shortening fraction &gt; 30 % ejection fraction &gt; 45 % . Liver : total bilirubin &lt; 2 × upper limit normal ; ALT &lt; 3 × upper Kidney : creatinine &lt; 2 × normal creatinine clearance ( GFR ) &gt; 60 ml/min/1.73m2 . 6 . Patients must lack active viral infection active fungal infection . 7 . Appropriate donor available : Matched 6/6 A , B , DR locus . 8 . Patients ( one parent patient age &lt; 19 ) sign inform consent . 1 . Pregnant nursing woman . 2 . Malignant nonmalignant illness uncontrolled whose control may jeopardize complication study therapy . 3 . Psychiatric disorder would preclude compliance . 4 . Congenital aplastic anemia include Fanconi anemia . 5 . Manipulated bone marrow .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>